Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics
Year: 2020
Type: review
Abstract: The blood-brain barrier (BBB) acts as a barrier to prevent the central nervous system (CNS) from damage by substances that originate from the blood circulation. The BBB limits drug penetration into the brain and is one of the major clinical obstacles to the treatment of CNS diseases. Nanotechnology-based delivery systems have been tested for overcoming this barrier and releasing related drugs into the brain matrix. In this review, nanoparticles (NPs) from simple to developed delivery systems are discussed for the delivery of a drug to the brain. This review particularly focuses on polymeric nanomaterials that have been used for CNS treatment. Polymeric NPs such as polylactide (PLA), poly (D, L-lactide-co-glycolide) (PLGA), poly (ε-caprolactone) (PCL), poly (alkyl cyanoacrylate) (PACA), human serum albumin (HSA), gelatin, and chitosan are discussed in detail.
Source: Biomedicines
Authors: Shahryar Shakeri(Conceptualization, Writing – original draft), Milad Ashrafizadeh(Writing – original draft), Ali Zarrabi(Writing – original draft), Rasoul Roghanian(Writing – original draft), Elham Ghasemipour Afshar(Writing – original draft), Abbas Pardakhty(Writing – review & editing), Reza Mohammadinejad(Writing – review & editing), Anuj Kumar(Writing – review & editing), Vijay Kumar Thakur(Writing – review & editing)
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $1,479
OpenAlex ID: W3000129071
